PHT Corporation Achieves 125% Increase in Demand for Patient-Driven eData Systems in 1st Quarter 2014

BOSTON and GENEVA, April 17, 2014 /PRNewswire/ -- PHT Corporation bookings grew by more than 125% during the first quarter of 2014 over the same period in 2013. PHT is the leading provider of technologies used to collect patient-driven eData for clinical research.  PHT provides sponsors and CROs the flexibility to deploy clinical outcome assessments on the web, smartphones and tablets including patients' own devices. 

The PHT electronic clinical outcome assessment (eCOA) System was chosen by 14 different pharmaceutical and biotechnology companies to collect compliant, patient-driven eData for 28 trials and studies in therapeutic areas including respiratory, CNS and oncology and for indications such as COPD, asthma, migraine, and cancer cachexia. PHT added two new clients through direct sales and CRO partnerships.

PHT President and CEO Philip Lee said, "Industry adoption of electronic patient reported outcomes and the PHT eCOA System has accelerated significantly over the past 12 months. PHT has been preparing for this growth by adding senior talent to the customer delivery team while focusing on an expanded suite of products, the PHT Patient Suite which delivers maximum ease of use for patients, sites and sponsors."  

Q1 Highlights:

Launch of New Mobile App – PHT launched an FDA Roadmap App to help sponsors navigate the Roadmap to Patient-Focused Outcome Measurement in Clinical Trials released by the FDA with their Clinical Outcome Assessment Qualification Program. The FDA Roadmap app optimizes the roadmap for Android phones and tablets.  Demo and download the Android app here:   http://www.phtcorp.com/Resources/Apps/FDA-Roadmap-App.aspx  or download it directly via Google Play: http://bit.ly/PHTs-FDA-Roadmap-Android

10^th Annual PRO & eCOA Congress – The U.S. PRO & eCOA Congress gathered pharmaceutical pacesetters who continue driving the development and global adoption of eCOA technologies that enable patient-centric research and speed the delivery of new drugs and therapies.  See Congress highlights here:  http://bit.ly/1qxtiQS

Industry Recognition – The PHT LogPad App™ System was a finalist for the Clinical Informatics News Best Practices Award for improving patient service. The mobile app collects compliant patient reported outcomes (PROs) using smartphones.

PHT Vice President of Marketing and Product Management Sheila Rocchio, MBA, added, "PHT is delivering products that enable customers and partners to support more patient-centric trials including support for the 'Bring Your Own Device' [BYOD] model. Also, the PHT Medication Module is helping sponsors and patients more accurately track and manage rescue and concomitant medication in real time, resulting in a better trial experience for both patients and sites."  Watch Sheila Rocchio discuss the PHT vision of offering a patient suite for clinical trials to collect data and promote patient healthcare, and an app for every trial to enable truly patient-centric research:
http://bit.ly/PatientSuite

Last quarter PHT continued to lead the discussion about improving clinical research through technology as it sponsored the first "International #PatientBYOD Day" which gathered opinions worldwide about the BYOD model that advances eClinical technologies for patient-centric research. http://bit.ly/PatientBYOD

Attend the PRO & eCOA Congress, Europe, June 3-5, Barcelona and join the most progressive minds in Europe's pharmaceutical research community. Meet PHT at the Outsourcing in Clinical Trials Europe, 21-22 May to be entered to win one free PRO & eCOA Congress registration and hotel accommodation in Barcelona.  

About PHT Corporation
PHT Corporation is the eClinical innovator leading the adoption of patient-driven mobile apps for better clinical research. The PHT electronic clinical outcome assessment (eCOA) system collects and reports secure real-time patient data from the latest mobile devices. PHT scientific, regulatory and technological expertise combined with quality outcomes data enable clients to make research decisions with confidence. Sponsors and CROs have leveraged the PHT Patient Suite in 650+ trials resulting in 16+ regulatory approvals. Visit phtcorp.com for more information on PHT. Join the PRO & eCOA Congress LinkedIn Community.Follow PHT on LinkedIn, Twitter, Google+ and YouTube.

Video - http://www.youtube.com/watch?v=kglaSAc98TY&list=UU4F3XHU9fi9Y4vGKjNQvjNA

SOURCE PHT Corporation